bioRxivCancer BiologyPreprint
MAPK-mediated PHGDH induction is essential for melanoma formation and represents an actionable vulnerability
N. Jasani, X. Xu, B. Posorske, Y. Kim, O. Vera, K. Y. Tsai, G. M. DeNicola, F. A. Karreth
Abstract
ABSTRACTOverexpression of PHGDH, the rate-limiting enzyme in the serine synthesis pathway, promotes melanomagenesis, melanoma cell proliferation, and survival of metastases in serine-low environments such as the brain. While PHGDH amplification explains PHGDH overexpression in a subset of melanomas, we find that PHGDH levels are universally increased in melanoma cells due to oncogenic BRAFV600E promoting PHGDH transcription through mTORC1-mediated translation of ATF4. Importantly, PHGDH expression was critical for melanomagenesis as depletion of PHGDH in genetic mouse models blocked melanoma formation. Despite BRAFV600E- mediated upregulation, PHGDH was further induced by exogenous serine restriction. Surprisingly, BRAFV600E inhibition diminished serine restriction-mediated PHGDH expression by preventing ATF4 induction, creating a potential vulnerability whereby melanoma cells could be specifically starved of serine by combining BRAFV600E inhibition with exogenous serine restriction. Indeed, we show that this combination promoted cell death in vitro and attenuated melanoma growth in vivo. This study identified a melanoma cell-specific PHGDH-dependent vulnerability.
- organism: mouse
- assay: bulk RNA-seq
- research focus: cancer & tumor microenvironment
- research focus: cell type annotation
- research focus: drug response / drug discovery
- approach: experimental assay
- approach: wet-lab / biochemical assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Increased PHGDH expression uncouples hair follicle cycle progression and promotes inappropriate melanin accumulation
Katherine R. Mattaini, Mark R. Sullivan, … Matthew G. Vander Heiden·bioRxiv·Jan 17, 2018
- The dynamics of ERK signaling in melanoma, and the response to BRAF or MEK inhibition, are cell cycle dependent.
Chloe M. Simpson, Nicola Ferrari, … Chris Bakal·bioRxiv·Aug 13, 2018
- Translational control of AMPK activity in melanoma
Natália Vadovičová, Anna Lešková, … Stjepan Uldrijan·Cell Communication and SignalingPeer-reviewed·Apr 28, 2026
- Tumorigenesis driven by the BRAF V600E oncoprotein requires secondary mutations that overcome its feedback inhibition of migration and invasion
s. gadal, J. A. Boyer, … N. Rosen·bioRxiv·Nov 21, 2023
- Melanoma Addiction to GCDH is Mediated by NRF2 Tumor Suppressor Function
S. Verma, D. Crawford, … Z. A. Ronai·bioRxiv·Oct 22, 2021
- Inactivation of the Hippo Tumor Suppressor Pathway Promotes Melanoma
M. A. Vittoria, N. M. Kingston, … N. J. Ganem·bioRxiv·May 4, 2021